These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

417 related items for PubMed ID: 23774005

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Use of high-dose liposomal amphotericin B: efficacy and tolerance.
    Garbino J, Adam A.
    Acta Biomed; 2006; 77 Suppl 4():19-22. PubMed ID: 17370566
    [Abstract] [Full Text] [Related]

  • 45. Comparison of the safety and cost-effectiveness of nebulized liposomal amphotericin B and amphotericin B deoxycholate for antifungal prophylaxis after lung transplantation.
    Umemura K, Katada Y, Nakagawa S, Hira D, Yutaka Y, Tanaka S, Ohsumi A, Nakajima D, Date H, Nagao M, Terada T.
    J Infect Chemother; 2024 Aug; 30(8):741-745. PubMed ID: 38354908
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Burden of acute kidney injury in HIV patients under deoxycholate amphotericin B therapy for cryptococcal meningitis and cost-minimization analysis of amphotericin B lipid complex.
    Tuon FF, Florencio KL, Rocha JL.
    Med Mycol; 2019 Apr 01; 57(3):265-269. PubMed ID: 29762761
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Renal effects of amphotericin B lipid complex.
    Luke RG, Boyle JA.
    Am J Kidney Dis; 1998 May 01; 31(5):780-5. PubMed ID: 9590187
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Comparative analysis of amphotericin B lipid complex and liposomal amphotericin B kinetics of lung accumulation and fungal clearance in a murine model of acute invasive pulmonary aspergillosis.
    Lewis RE, Liao G, Hou J, Chamilos G, Prince RA, Kontoyiannis DP.
    Antimicrob Agents Chemother; 2007 Apr 01; 51(4):1253-8. PubMed ID: 17261624
    [Abstract] [Full Text] [Related]

  • 52. Nephrotoxicity in the setting of invasive fungal diseases.
    Ullmann AJ.
    Mycoses; 2008 Apr 01; 51 Suppl 1():25-30. PubMed ID: 18471158
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Outcomes associated with amphotericin B lipid complex (ABLC) prophylaxis in high-risk liver transplant patients.
    Saliba F, Delvart V, Ichaï P, Kassis N, Botterel F, Mihaila L, Azoulay D, Adam R, Castaing D, Bretagne S, Samuel D.
    Med Mycol; 2013 Feb 01; 51(2):155-63. PubMed ID: 22800082
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Corneal concentrations following systemic administration of amphotericin B and its lipid preparations in a rabbit model.
    Goldblum D, Rohrer K, Frueh BE, Theurillat R, Thormann W, Zimmerli S.
    Ophthalmic Res; 2004 Feb 01; 36(3):172-6. PubMed ID: 15103209
    [Abstract] [Full Text] [Related]

  • 58. Liposomal and lipid-based formulations of amphotericin B.
    de Marie S.
    Leukemia; 1996 Jun 01; 10 Suppl 2():s93-6. PubMed ID: 8649062
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Continuous infusion of escalated doses of amphotericin B deoxycholate: an open-label observational study.
    Imhof A, Walter RB, Schaffner A.
    Clin Infect Dis; 2003 Apr 15; 36(8):943-51. PubMed ID: 12684904
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.